Intermediate and long-term followup of percutaneous device closure of fossa ovalis atrial septal defect by the Amplatzer septal occluder in a cohort of 529 patients.
about
Percutaneous closure of secundum type atrial septal defects: More than 5-year follow-up.Echocardiographic Evaluation of Changes in Cardiac Hemodynamics and Loading Conditions after Transthoracic Minimally Invasive Device Closure of Atrial Septal Defect.Device closure in adults with atrial septal defect in Shiraz, a single center registry.Amplatzer occluder versus CardioSEAL/STARFlex occluder: a meta-analysis of the efficacy and safety of transcatheter occlusion for patent foramen ovale and atrial septal defect.Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies.Mid-Term Outcomes after Percutaneous Closure of the Secundum Atrial Septal Defect with the Figulla-Occlutech Device.Initial use of the new GORE(®) septal occluder in patent foramen ovale closure: implantation and preliminary results.Totally Endoscopic Cardiac Surgery for Atrial Septal Defect Repair on Beating Heart Without Robotic Assistance in 25 Patients.Comparison of the Occlutech ® Figulla ® septal occluder and Amplatzer ® septal occluder for atrial septal defect device closure.Antiplatelet effects of clopidogrel and aspirin after interventional patent foramen ovale/ atrium septum defect closure.
P2860
Q35193479-F7079C3F-0E6C-4A11-B169-EF40D0DF566EQ35683697-F3E0A27B-AE85-49AC-A724-61625D176E59Q36785466-BD4C2B45-1EBF-4948-9C69-64B2882FA731Q38063980-24E10610-5EF7-4BD9-9A31-913FFD5E2320Q38081829-8D0F7E43-3A66-459A-82AC-52799B07DDFFQ39958916-0F70F97F-0B74-49FC-9496-31B7B645F5B0Q43572652-7CC3FDE6-9AB9-4C7F-B827-6BC77C56C616Q49657811-878E844D-E97B-4861-AA26-7611623DC7E2Q51061337-434205DC-80EB-4F65-973D-038A35C104CBQ52903388-AB7FF28D-9EC2-4966-A647-2C4C8F1A4138
P2860
Intermediate and long-term followup of percutaneous device closure of fossa ovalis atrial septal defect by the Amplatzer septal occluder in a cohort of 529 patients.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Intermediate and long-term fol ...... r in a cohort of 529 patients.
@ast
Intermediate and long-term fol ...... r in a cohort of 529 patients.
@en
type
label
Intermediate and long-term fol ...... r in a cohort of 529 patients.
@ast
Intermediate and long-term fol ...... r in a cohort of 529 patients.
@en
prefLabel
Intermediate and long-term fol ...... r in a cohort of 529 patients.
@ast
Intermediate and long-term fol ...... r in a cohort of 529 patients.
@en
P2093
P2860
P356
P1476
Intermediate and long-term fol ...... r in a cohort of 529 patients.
@en
P2093
Munesh Tomar
Sanjay Khatri
Savitri Shrivastava
Sitaraman Radhakrishnan
P2860
P356
10.4103/0974-2069.79618
P407
P577
2011-01-01T00:00:00Z